Gene · 8647
Papers3,310
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,310
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Synthesis, Antimalarial, Antileishmanial, and Cytotoxicity Activities and Preliminary In Silico ADMET Studies of 2-(7-Chloroquinolin-4-ylamino)ethyl Benzoate Derivatives. | Pharmaceuticals (Basel) | 2023 | 38139835 | PubTator, text mining | PubMed |
| Cranberry Proanthocyanidins Mitigate Reflux-Induced Transporter Dysregulation in an Esophageal Adenocarcinoma Model. | Pharmaceuticals (Basel) | 2023 | 38139823 | PubTator, text mining | PubMed |
| Berberine Protects against High-Energy and Low-Protein Diet-Induced Hepatic Steatosis: Modulation of Gut Microbiota and Bile Acid Metabolism in Laying Hens. | Int J Mol Sci | 2023 | 38139133 | PubTator, text mining | PubMed |
| Single-cell transcriptomics identifies adipose tissue CD271+ progenitors for enhanced angiogenesis in limb ischemia. | Cell Rep Med | 2023 | 38118404 | PubTator, text mining | PubMed |
| Insight into the mechanism of gallstone disease by proteomic and metaproteomic characterization of human bile. | Front Microbiol | 2023 | 38111640 | PubTator, text mining | PubMed |
| Ribociclib-induced liver injury: a case report. | Front Oncol | 2023 | 38107071 | PubTator, text mining | PubMed |
| DNDI-6174 is a preclinical candidate for visceral leishmaniasis that targets the cytochrome bc1. | Sci Transl Med | 2023 | 38091406 | PubTator, text mining | PubMed |
| Gardenia Iridoid Glucosides Protect Against α-Naphthalene Isothiocya-Nate-Induced Cholestatic Rats Through Activation of the FXR-SHP Signaling Pathway. | Clin Exp Gastroenterol | 2023 | 38090678 | PubTator, text mining | PubMed |
| The diagnostic yield of exome sequencing in liver diseases from a curated gene panel. | Sci Rep | 2023 | 38057357 | PubTator, text mining | PubMed |
| Gut liver brain axis in diseases: the implications for therapeutic interventions. | Signal Transduct Target Ther | 2023 | 38057297 | PubTator, text mining | PubMed |
| Association between viral infections and glioma risk: a two-sample bidirectional Mendelian randomization analysis. | BMC Med | 2023 | 38053181 | PubTator, text mining | PubMed |
| A Rare Case of Progressive Familial Intrahepatic Cholestasis Type 4: A Case Report and Literature Review. | Cureus | 2023 | 38021987 | PubTator, text mining | PubMed |
| Idiopathic pulmonary fibrosis: Addressing the current and future therapeutic advances along with the role of Sotatercept in the management of pulmonary hypertension. | Immun Inflamm Dis | 2023 | 38018591 | PubTator, text mining | PubMed |
| A Literature Review of Changes in Phase II Drug-Metabolizing Enzyme and Drug Transporter Expression during Pregnancy. | Pharmaceutics | 2023 | 38004602 | PubTator, text mining | PubMed |
| Research progress on the relationship between bile acid metabolism and type 2 diabetes mellitus. | Diabetol Metab Syndr | 2023 | 37978556 | PubTator, text mining | PubMed |
| Transmembrane Helices 7 and 8 Confer Aggregation Sensitivity to the Cystic Fibrosis Transmembrane Conductance Regulator. | Int J Mol Sci | 2023 | 37958724 | PubTator, text mining | PubMed |
| The Role of Galectin-3 in Retinal Degeneration and Other Ocular Diseases: A Potential Novel Biomarker and Therapeutic Target. | Int J Mol Sci | 2023 | 37958500 | PubTator, text mining | PubMed |
| Structural basis of bile salt extrusion and small-molecule inhibition in human BSEP. | Nat Commun | 2023 | 37949847 | PubTator, text mining | PubMed |
| Personalized drug screening in patient-derived organoids of biliary tract cancer and its clinical application. | Cell Rep Med | 2023 | 37944531 | PubTator, text mining | PubMed |
| Gut microbiota depletion aggravates bile acid-induced liver pathology in mice with a human-like bile acid composition. | Clin Sci (Lond) | 2023 | 37910096 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8647/papers?page=12